Looking forwards: future avenues of research for incretin biology Looking forwards: future avenues of research for incretin biology Several factors hampered (and continue to challenge) clinical development of GLP agonist therapies
By targeting hormones that regulate appetite and glucose metabolism, tirzepatide provides a holistic solution for long-term weight management
Li X, Wang Z, Wang H, Xu H, Sheng Y, Lian F
In 2010, the first human trial using RNAi technology was conducted to evaluate the therapeutic effect of siRNA for targeting the M2 subunit of ribonucleotide reductase in patients with melanoma
Many individuals feel the change in how their skin looks and this is sufficient reason for sticking with this kind of whitening therapy
Dihexa (PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a potent hepatocyte growth factor (HGF) receptor agonist originally developed at Washington State University